Adar Poonawalla, CEO, Serum Institute of India (SII), said on Thursday that building up an antibody resembles a rollercoaster ride with high points and low points.
<blockquote>"Building up an antibody resembles riding a rollercoaster; there are a lot of high points and low points. Some of the time we come up short, here and there we succeed, yet we should be persistent and not make a hasty judgment too soon. We should trust that all stage 3 preliminaries will be finished," Poonawalla said in a tweet.</blockquote>
There have been reports that one of the solid contender for a potential antibody for Covid-19 being tried by specialists at the Oxford University has neglected to shield monkeys from being tainted by the infection. Be that as it may, the potential antibody assisted with shielding the monkeys from pneumonia.

Reports of the Oxford antibody's exhibition on monkeys had incited specialists to test the immunization's strength in people.

The capability of the antibody had likewise prompted the Serum Institute reporting intends to fabricate four to 5,000,000 dosages in India. It is one of seven worldwide organizations that will make the antibody being created by the Oxford Vaccine Group.